Insilico to present latest advances in Machine Learning & Artificial Intelligence for drug discovery

(InSilico Medicine, Inc.) Insilico Medicine presents at the Advanced Machine Learning and Artificial Intelligence for Drug Discovery & Development Conference, organized by BIS Group. The presentation will focus on the application of Generative Adversarial Networks (GANs) for generation of novel small organic molecules with the desired set of pharmacological properties.